Bayer/Regeneron Will Initiate VEGF Trap-Eye Phase III Trial In Second Half
This article was originally published in The Pink Sheet Daily
Executive Summary
Further development follows the release of a positive Phase II interim analysis of the wet age-related macular degeneration candidate.